PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus

BACKGROUND: Genetic polymorphisms in the PPARD and NOS1AP is associated with type 2 diabetes mellitus (T2DM); however, there is no evidence about its impact on the therapeutic efficacy of nateglinide. This study was designed to investigate a potential association of PPARD rs2016520 (T/C) and NOS1AP...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Song, Jin-Fang, Zhou, Xue-Yan, Li, Cheng-Lin, Yin, Xiao-Xing, Lu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588701/
https://www.ncbi.nlm.nih.gov/pubmed/34772419
http://dx.doi.org/10.1186/s12920-021-01108-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588701/
https://www.ncbi.nlm.nih.gov/pubmed/34772419
http://dx.doi.org/10.1186/s12920-021-01108-5

Ejemplares similares